Cargando…
Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
Currently, the assessment of immunological risk in lung transplantation (LTx) does not completely consider HLA compatibility at the molecular level. We have previously demonstrated the association of HLA eplets in predicting chronic lung allograft dysfunction following LTx; however, the associations...
Autores principales: | Hiho, Steven J., Walton, Duncan C., Paraskeva, Miranda A., Levvey, Bronwyn J., Diviney, Mary B., Snell, Gregory I., Sullivan, Lucy C., Westall, Glen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529050/ https://www.ncbi.nlm.nih.gov/pubmed/36204183 http://dx.doi.org/10.1097/TXD.0000000000001364 |
Ejemplares similares
-
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021) -
Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017) -
Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
por: Li, Jenny, et al.
Publicado: (2023) -
DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation
por: González-López, Elena, et al.
Publicado: (2023) -
The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)